Skip to main content Back to Top
Advertisement

9/12/2019

Meperidine Hydrochloride Injection

Products Affected - Description

    • Demerol injection, Pfizer, 100 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1180-69
    • Demerol injection, Pfizer, 100 mg/mL, 1 mL ampule, 25 count, NDC 00409-1256-01
    • Demerol injection, Pfizer, 100 mg/mL, 20 mL multiple dose vial, 1 count, NDC 00409-1201-20
    • Demerol injection, Pfizer, 25 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1176-30
    • Demerol injection, Pfizer, 50 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1178-30
    • Demerol injection, Pfizer, 50 mg/mL, 1 mL ampule, 25 count, NDC 00409-1253-01
    • Demerol injection, Pfizer, 50 mg/mL, 1.5 mL ampule, 25 count, NDC 00409-1254-01
    • Demerol injection, Pfizer, 75 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1179-30
    • Meperidine injection, ICU Medical, 10 mg/mL, 30 mL PCA glass vial, 10 count, NDC 00409-6030-04 - discontinued

Reason for the Shortage

    • Pfizer has Demerol injection on shortage due to manufacturing delays.
    • ICU Medical discontinued meperidine 30 mL PCA vials.

Available Products

    • Demerol injection, Pfizer, 50 mg/mL, 0.5 mL ampule, 25 count, NDC 00409-1203-01
    • Demerol injection, Pfizer, 50 mg/mL, 2 mL ampule, 25 count, NDC 00409-1255-02
    • Demerol injection, Pfizer, 50 mg/mL, 30 mL multiple dose vial, 1 count, NDC 00409-1181-30
    • Meperidine injection, Hikma, 100 mg/mL, 1 mL vial, 25 count, NDC 00641-6054-25
    • Meperidine injection, Hikma, 25 mg/mL, 1 mL vial, 25 count, NDC 00641-6052-25
    • Meperidine injection, Hikma, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-6053-25

Estimated Resupply Dates

    • Pfizer has Demerol 100 mg/mL 20 mL vials and on back order and the company estimates a release date of June 2020. The 25 mg/mL 1 mL Carpuject syringes, 50 mg/mL 1 mL Carpuject syringes, 75 mg/mL 1 mL Carpuject syringes, 100 mg/mL 1 mL Carpuject syringes, and 50 mg/mL 1 mL and 1.5 mL ampules are on back order and the company estimates a release date of October 2020. The 100 mg/mL 1 mL ampules are on back order and the company estimates a release date of September 2019.

Updated

Updated September 12, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 19, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins